awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35761718-C41EACD0-9EC7-4436-BC95-D9980352F2CE
Q35761718-C41EACD0-9EC7-4436-BC95-D9980352F2CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35761718-C41EACD0-9EC7-4436-BC95-D9980352F2CE
Efficacy of imatinib dose escalation in Chinese gastrointestinal stromal tumor patients.
P2860
Q35761718-C41EACD0-9EC7-4436-BC95-D9980352F2CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35761718-C41EACD0-9EC7-4436-BC95-D9980352F2CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8277940c668485fd7f73d782a6114b5ceca282f1
P2860
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.